{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:30:25Z","timestamp":1790775025317,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T00:00:00Z","timestamp":1524700800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creat1vecommons.org\/pub\/icdomain\/zero\/l.O\/"}],"funder":[{"name":"NIH T32 Ruth L. Kirschstein National Research Service Award","award":["2T32CA117846-06A1"],"award-info":[{"award-number":["2T32CA117846-06A1"]}]},{"name":"The Cyril Gilbert Testimonial Fund and the Gallipoli Medical Research Foundation"},{"name":"Lcs Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12885-018-4389-3","type":"journal-article","created":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T23:06:18Z","timestamp":1524697578000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":112,"title":["Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4649-6999","authenticated-orcid":false,"given":"Brian J.","family":"Morrison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason C.","family":"Steel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,26]]},"reference":[{"issue":"7","key":"4389_CR1","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1053\/j.gastro.2007.04.025","volume":"132","author":"S Ma","year":"2007","unstructured":"Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, et al. Identification and characterization of tumorigenic liver cancer stem\/progenitor cells. Gastroenterology. 2007;132(7):2542\u201356.","journal-title":"Gastroenterology"},{"issue":"3","key":"4389_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11523-012-0247-4","volume":"8","author":"BJ Morrison","year":"2013","unstructured":"Morrison BJ, Morris JC, Steel JC. Lung cancer-initiating cells: a novel target for cancer therapy. Target Oncol. 2013;8(3):159\u201372.","journal-title":"Target Oncol"},{"issue":"6","key":"4389_CR3","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.ctrv.2012.03.003","volume":"38","author":"MR Alison","year":"2012","unstructured":"Alison MR, Lin WR, Lim SM, Nicholson LJ. Cancer stem cells: in the line of fire. Cancer Treat Rev. 2012;38(6):589\u201398.","journal-title":"Cancer Treat Rev"},{"issue":"7120","key":"4389_CR4","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/nature05236","volume":"444","author":"S Bao","year":"2006","unstructured":"Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444(7120):756\u201360.","journal-title":"Nature"},{"issue":"7239","key":"4389_CR5","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/nature07733","volume":"458","author":"M Diehn","year":"2009","unstructured":"Diehn M, Cho RW, Lobo NA, Kalisky T, Dorie MJ, Kulp AN, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009;458(7239):780\u20133.","journal-title":"Nature"},{"issue":"7412","key":"4389_CR6","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nature11287","volume":"488","author":"J Chen","year":"2012","unstructured":"Chen J, Li Y, Yu TS, McKay RM, Burns DK, Kernie SG, et al. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature. 2012;488(7412):522\u20136.","journal-title":"Nature"},{"issue":"1","key":"4389_CR7","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/ng.2481","volume":"45","author":"Y Nakanishi","year":"2013","unstructured":"Nakanishi Y, Seno H, Fukuoka A, Ueo T, Yamaga Y, Maruno T, et al. Dclk1 distinguishes between tumor and normal stem cells in the intestine. Nat Genet. 2013;45(1):98\u2013103.","journal-title":"Nat Genet"},{"issue":"23","key":"4389_CR8","doi-asserted-by":"publisher","first-page":"8886","DOI":"10.1158\/0008-5472.CAN-09-2687","volume":"69","author":"CE Brown","year":"2009","unstructured":"Brown CE, Starr R, Martinez C, Aguilar B, D'Apuzzo M, Todorov I, et al. Recognition and killing of brain tumor stem-like initiating cells by CD8+ cytolytic T cells. Cancer Res. 2009;69(23):8886\u201393.","journal-title":"Cancer Res"},{"issue":"5","key":"4389_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/PPO.0b013e318233e730","volume":"17","author":"MV Dhodapkar","year":"2011","unstructured":"Dhodapkar MV, Dhodapkar KM. Vaccines targeting cancer stem cells: are they within reach? Cancer J. 2011;17(5):397\u2013402.","journal-title":"Cancer J"},{"issue":"5","key":"4389_CR10","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2217\/fon.13.38","volume":"9","author":"BJ Morrison","year":"2013","unstructured":"Morrison BJ, Steel JC, Morris JC. Immunotherapy in lung cancer: the potential of cancer stem cells in future therapies. Future Oncol. 2013;9(5):623\u20135.","journal-title":"Future Oncol"},{"issue":"11","key":"4389_CR11","doi-asserted-by":"publisher","first-page":"e49752","DOI":"10.1371\/journal.pone.0049752","volume":"7","author":"BJ Morrison","year":"2012","unstructured":"Morrison BJ, Steel JC, Morris JC. Sphere culture of murine lung cancer cell lines are enriched with cancer initiating cells. PLoS One. 2012;7(11):e49752.","journal-title":"PLoS One"},{"issue":"12","key":"4389_CR12","doi-asserted-by":"publisher","first-page":"e52692","DOI":"10.1371\/journal.pone.0052692","volume":"7","author":"BJ Morrison","year":"2012","unstructured":"Morrison BJ, Hastie ML, Grewal YS, Bruce ZC, Schmidt C, Reynolds BA, et al. Proteomic comparison of mcf-7 tumoursphere and monolayer cultures. PLoS One. 2012;7(12):e52692.","journal-title":"PLoS One"},{"issue":"6","key":"4389_CR13","doi-asserted-by":"publisher","first-page":"e64388","DOI":"10.1371\/journal.pone.0064388","volume":"8","author":"CE Smart","year":"2013","unstructured":"Smart CE, Morrison BJ, Saunus JM, Vargas AC, Keith P, Reid L, et al. In vitro analysis of breast cancer cell line tumourspheres and primary human breast epithelia mammospheres demonstrates inter- and intrasphere heterogeneity. PLoS One. 2013;8(6):e64388.","journal-title":"PLoS One"},{"issue":"1","key":"4389_CR14","doi-asserted-by":"publisher","first-page":"e15844","DOI":"10.1371\/journal.pone.0015844","volume":"6","author":"LP Deleyrolle","year":"2011","unstructured":"Deleyrolle LP, Ericksson G, Morrison BJ, Lopez JA, Burrage K, Burrage P, et al. Determination of somatic and cancer stem cell self-renewing symmetric division rate using sphere assays. PLoS One. 2011;6(1):e15844.","journal-title":"PLoS One"},{"issue":"1","key":"4389_CR15","doi-asserted-by":"publisher","first-page":"350","DOI":"10.4049\/jimmunol.169.1.350","volume":"169","author":"S Zwaveling","year":"2002","unstructured":"Zwaveling S, Ferreira Mota SC, Nouta J, Johnson M, Lipford GB, Offringa R, et al. Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides. J Immunol. 2002;169(1):350\u20138.","journal-title":"J Immunol"},{"issue":"11","key":"4389_CR16","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/sj.bjc.6605642","volume":"102","author":"P Workman","year":"2010","unstructured":"Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ, et al. Guidelines for the welfare and use of animals in cancer research. Br J Cancer. 2010;102(11):1555\u201377.","journal-title":"Br J Cancer"},{"issue":"1\u20132","key":"4389_CR17","first-page":"70","volume":"347","author":"Y Hu","year":"2009","unstructured":"Hu Y, Smyth GK. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods. 2009;347(1\u20132):70\u20138.","journal-title":"J Immunol Methods"},{"issue":"1","key":"4389_CR18","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/(SICI)1097-0215(19980925)78:1<41::AID-IJC8>3.0.CO;2-X","volume":"78","author":"H Ji","year":"1998","unstructured":"Ji H, Chang EY, Lin KY, Kurman RJ, Pardoll DM, Wu TC. Antigen-specific immunotherapy for murine lung metastatic tumors expressing human papillomavirus type 16 E7 oncoprotein. Int J Cancer. 1998;78(1):41\u20135.","journal-title":"Int J Cancer"},{"issue":"2","key":"4389_CR19","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1750-3639.2011.00515.x","volume":"22","author":"T Avril","year":"2012","unstructured":"Avril T, Vauleon E, Hamlat A, Saikali S, Etcheverry A, Delmas C, et al. Human glioblastoma stem-like cells are more sensitive to allogeneic NK and T cell-mediated killing compared with serum-cultured glioblastoma cells. Brain Pathol. 2012;22(2):159\u201374.","journal-title":"Brain Pathol"},{"issue":"6","key":"4389_CR20","doi-asserted-by":"publisher","first-page":"3530","DOI":"10.4049\/jimmunol.0802845","volume":"182","author":"R Castriconi","year":"2009","unstructured":"Castriconi R, Daga A, Dondero A, Zona G, Poliani PL, Melotti A, et al. NK cells recognize and kill human glioblastoma cells with stem cell-like properties. J Immunol. 2009;182(6):3530\u20139.","journal-title":"J Immunol"},{"issue":"3","key":"4389_CR21","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1158\/1078-0432.CCR-09-2730","volume":"16","author":"T Di Tomaso","year":"2010","unstructured":"Di Tomaso T, Mazzoleni S, Wang E, Sovena G, Clavenna D, Franzin A, et al. Immunobiological characterization of cancer stem cells isolated from glioblastoma patients. Clin Cancer Res. 2010;16(3):800\u201313.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"4389_CR22","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2174\/156720112798375989","volume":"9","author":"A Jewett","year":"2012","unstructured":"Jewett A, Tseng HC, Arasteh A, Saadat S, Christensen RE, Cacalano NA. Natural killer cells preferentially target cancer stem cells; role of monocytes in protection against NK cell mediated lysis of cancer stem cells. Curr Drug Deliv. 2012;9(1):5\u201316.","journal-title":"Curr Drug Deliv"},{"issue":"7","key":"4389_CR23","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1093\/intimm\/dxp047","volume":"21","author":"G Pietra","year":"2009","unstructured":"Pietra G, Manzini C, Vitale M, Balsamo M, Ognio E, Boitano M, et al. Natural killer cells kill human melanoma cells with characteristics of cancer stem cells. Int Immunol. 2009;21(7):793\u2013801.","journal-title":"Int Immunol"},{"issue":"5","key":"4389_CR24","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.4049\/jimmunol.1201542","volume":"190","author":"R Tallerico","year":"2013","unstructured":"Tallerico R, Todaro M, Di Franco S, Maccalli C, Garofalo C, Sottile R, et al. Human NK cells selective targeting of colon cancer-initiating cells: a role for natural cytotoxicity receptors and MHC class I molecules. J Immunol. 2013;190(5):2381\u201390.","journal-title":"J Immunol"},{"issue":"7","key":"4389_CR25","doi-asserted-by":"publisher","first-page":"e11590","DOI":"10.1371\/journal.pone.0011590","volume":"5","author":"HC Tseng","year":"2010","unstructured":"Tseng HC, Arasteh A, Paranjpe A, Teruel A, Yang W, Behel A, et al. Increased lysis of stem cells but not their differentiated cells by natural killer cells; de-differentiation or reprogramming activates NK cells. PLoS One. 2010;5(7):e11590.","journal-title":"PLoS One"},{"issue":"2","key":"4389_CR26","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11060-006-9265-3","volume":"83","author":"A Wu","year":"2007","unstructured":"Wu A, Wiesner S, Xiao J, Ericson K, Chen W, Hall WA, et al. Expression of MHC I and NK ligands on human CD133+ glioma cells: possible targets of immunotherapy. J Neuro-Oncol. 2007;83(2):121\u201331.","journal-title":"J Neuro-Oncol"},{"issue":"2","key":"4389_CR27","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0165-0378(98)00009-6","volume":"38","author":"G Ljunggren","year":"1998","unstructured":"Ljunggren G, Anderson DJ. Cytokine induced modulation of MHC class I and class II molecules on human cervical epithelial cells. J Reprod Immunol. 1998;38(2):123\u201338.","journal-title":"J Reprod Immunol"},{"issue":"6","key":"4389_CR28","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1177\/1758834016661164","volume":"8","author":"G Schvartsman","year":"2016","unstructured":"Schvartsman G, Ferrarotto R, Massarelli E. Checkpoint inhibitors in lung cancer: latest developments and clinical potential. Ther Adv Med Oncol. 2016;8(6):460\u201373.","journal-title":"Ther Adv Med Oncol"},{"issue":"1","key":"4389_CR29","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00432-012-1311-2","volume":"139","author":"T Liao","year":"2013","unstructured":"Liao T, Kaufmann AM, Qian X, Sangvatanakul V, Chen C, Kube T, et al. Susceptibility to cytotoxic T cell lysis of cancer stem cells derived from cervical and head and neck tumor cell lines. J Cancer Res Clin Oncol. 2013;139(1):159\u201370.","journal-title":"J Cancer Res Clin Oncol"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4389-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12885-018-4389-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-018-4389-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,25]],"date-time":"2019-04-25T19:15:13Z","timestamp":1556219713000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-018-4389-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,26]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["4389"],"URL":"https:\/\/doi.org\/10.1186\/s12885-018-4389-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,26]]},"assertion":[{"value":"5 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was reviewed and approved by the University of Cincinnati Institutional Animal Care and Use Committee (IACUC) in compliance with all applicable Federal regulations governing protection of animals in research. All efforts were made to minimize animal suffering. For all animal studies humane endpoints were utilized to prevent unalleviated pain.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare they have no competing interests. BJM is a military service member. The work of this individual was prepared as part of official government duties. Title 17\u00a0U.S.C. \u00a7105 provides that Copyright protection under this title is not available for any work of the United States Government. Title 17\u00a0U.S.C. \u00a7101 defines a U.S. Government work as a work prepared by a military service member or employee of the U.S. Government as part of that person\u2019s official duties. The views expressed in this article are those of the author and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the U.S. Government.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"469"}}